More languages – more opportunities! The list of AIDS2018 sessions recommended for simultaneous translation into Russian is now made public.

Russian-speaking participants of AIDS2018 will be happy to know that key sessions will be provided with simultaneous translation into Russian. These sessions are: Opening, Rapporteur & Closing, all plenary sessions (8:45-10:30 daily) and all special sessions (13:00-14:00 daily). Other sessions in the list are collected ...

July 12, 2018
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial and in rhesus monkeys
178  

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial and in rhesus monkeys

The mosaic Ad26/Ad26 plus gp140 HIV-1 vaccine induced comparable and robust immune responses in humans and rhesus monkeys, and it provided significant protection against repetitive heterologous SHIV challenges in rhesus monkeys. This vaccine concept is currently being evaluated in a phase 2b clinical efficacy study ...

July 09, 2018
San Francisco and Oakland to host AIDS 2020
218  

San Francisco and Oakland to host AIDS 2020

The International AIDS Society (IAS) has announced that San Francisco, California, in partnership with nearby Oakland, will host the 23rd International AIDS Conference (AIDS 2020). This is 30 years after the event was held there at the height of the epidemic in the United States. ...

June 21, 2018
Michel Kazatchkine as the new Chair of Board of AFEW
110  

Michel Kazatchkine as the new Chair of Board of AFEW

Between 2007 and 2012, Professor Michel Kazatchkine has been the executive Director of the Global Fund to fight AIDS, Tuberculosis and malaria. From 2012 to 2017, he served as the UN Secretary General’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia. He is ...

June 20, 2018
Many young MSM discontinue PrEP
165  

Many young MSM discontinue PrEP

A third of young men who have sex with men (MSM) discontinue pre-exposure prophylaxis (PrEP) within a six-month period, investigators from the United States report in AIDS and Behavior. Common reasons for stopping included being unable to get an appointment with a doctor and problems ...

June 04, 2018